Pharmabiz55m
NABH to conduct entry-level hospital assessors’ training programme in New Delhi from Oct 22 to 24
NABH to conduct entry-level hospital assessors’ training programme in New Delhi from Oct 22 to 24: Shardul Nautiyal, Mumbai ...
Pharmabiz55m
Karnataka pharmacists upload sales & rack stock of Schedule H & K drugs to bring in transparency in medicine dispensing
Pharmacists in Karnataka have started uploading sales and rack stock of Schedule H & K drugs on the state drugs control portal to bring in transparency in medicine dispensing. By mandating this ...
Pharmabiz55m
No new traditional retail shop opened in TN during the last five years due to mushrooming of chain pharmacies
Peethaambaran Kunnathoor, Chennai Thursday, October 10, 2024, 08:00 Hrs [IST] ...
Pharmabiz55m
NCCE recommends formation of expert committee to determine rates under Clinical Establishments Rules
NCCE recommends formation of expert committee to determine rates under Clinical Establishments Rules: Gireesh Babu, New Delhi Thursday, October 10, 2024, 08:00 Hrs [IST] The Natio ...
Pharmabiz55m
MvPI releases updated version of medical devices adverse event reporting form
MvPI releases updated version of medical devices adverse event reporting form: Our Bureau, New Delhi Thursday, October 10, 2024, 08:00 Hrs [IST] The Materiovigilance Programme of ...
Pharmabiz20h
ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries
ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries: London, UK Wednesday, October 9, 2024, 12:00 Hrs [IST] GSK plc announced that ...
Pharmabiz17h
ModeX Therapeutics secures $35 mn BARDA supplement to develop Covid multispecific antibodies and $16 mn to initiate influenza programme
Weston, Massachusetts Wednesday, October 9, 2024, 15:00 Hrs [IST] ...
Pharmabiz18h
GSK presents positive data from AReSVi-006 phase III trial of respiratory syncytial virus vaccine, Arexvy at CHEST 2024 annual meeting
GSK presents positive data from AReSVi-006 phase III trial of respiratory syncytial virus vaccine, Arexvy at CHEST 2024 annual meeting: London, UK Wednesday, October 9, 2024, 14:0 ...
Pharmabiz14h
Adcendo gets US FDA clearance to begin ADCElerate-01 phase I/II trial of ADCE-D01 in patients with metastatic and/or unresectable STS
Adcendo gets US FDA clearance to begin ADCElerate-01 phase I/II trial of ADCE-D01 in patients with metastatic and/or unresectable STS: Copenhagen, Denmark Wednesday, October 9, 20 ...
Pharmabiz16h
Aurigene announces phase 1 study for India’s first trial for novel autologous CAR-T cell therapy for multiple myeloma
Aurigene announces phase 1 study for India’s first trial for novel autologous CAR-T cell therapy for multiple myeloma: Our Bureau, Bengaluru Wednesday, October 9, 2024, 16:45 Hr ...
Pharmabiz15h
NIHR and the Office for Life Sciences fund new projects to drive earlier diagnosis of cancer
The NIHR and the Office for Life Sciences (OLS) have funded six projects through NIHR's Invention for Innovation (i4i) and the OLS Cancer Programme. These six projects are receiving almost £11 million ...
Pharmabiz18h
Philips and Siloam Hospitals sign AI capability MoU to support Indonesia’s healthcare transformation strategy
Philips and Siloam Hospitals sign AI capability MoU to support Indonesia’s healthcare transformation strategy: Jakarta, Indonesia Wednesday, October 9, 2024, 14:30 Hrs [IST] Roy ...